1. Henschke CI, McCauley DI, Yankelevitz DF, Naidich DP, McGuinness G, Miettinen OS, Libby DM, Pasmantier MW, Koizumi J, Altorki NK, Smith JP. Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet. 1999. 354:99–105.
2. Kim YK, Chung JK, Kim SK, Yeo JS, Park DJ, Jeong JM, Lee DS, Cho BY, Lee MC. Results of radioiodine treatment for distant metastases of differentiated thyroid carcinoma. Korean J Nucl Med. 2000. 34:107–118.
3. Trinidad S, Lisa JR, Rosenblatt MB. Bronchogenic Carcinoma Simulated by Metastatic Tumors. Cancer. 1963. 16:1521–1529.
4. Cahan WG, Shah JP, Castro EB. Benign solitary lung lesions in patients with cancer. Ann Surg. 1978. 187:241–244.
5. Snyder BJ, Pugatch RD. Imaging characteristics of metastatic disease to the chest. Chest Surg Clin N Am. 1998. 8:29–48.
6. Coppage L, Shaw C, Curtis AM. Metastatic disease to the chest in patients with extrathoracic malignancy. J Thorac Imaging. 1987. 2:24–37.
7. Wada N, Duh QY, Sugino K, Iwasaki H, Kameyama K, Mimura T, Ito K, Takami H, Takanashi Y. Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann Surg. 2003. 237:399–407.
8. Schlumberger MJ. Papillary and follicular thyroid carcinoma. N Engl J Med. 1998. 338:297–306.
9. Schlumberger M, Tubiana M, De Vathaire F, Hill C, Gardet P, Travagli JP, Fragu P, Lumbroso J, Caillou B, Parmentier C. Long-term results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma. J Clin Endocrinol Metab. 1986. 63:960–967.
10. Mazzaferri EL. An overview of the management of papillary and follicular thyroid carcinoma. Thyroid. 1999. 9:421–427.
11. Zettinig G, Fueger BJ, Passler C, Kaserer K, Pirich C, Dudczak R, Niederle B. Long-term follow-up of patients with bone metastases from differentiated thyroid carcinoma -- surgery or conventional therapy? Clin Endocrinol (Oxf). 2002. 56:377–382.
12. Wood WJ Jr, Singletary SE, Hickey RC. Current results of treatment for distant metastatic well-differentiated thyroid carcinoma. Arch Surg. 1989. 124:1374–1377.
13. Casara D, Rubello D, Saladini G, Masarotto G, Favero A, Girelli ME, Busnardo B. Different features of pulmonary metastases in differentiated thyroid cancer: natural history and multivariate statistical analysis of prognostic variables. J Nucl Med. 1993. 34:1626–1631.
14. Schlumberger M, Challeton C, De Vathaire F, Travagli JP, Gardet P, Lumbroso JD, Francese C, Fontaine F, Ricard M, Parmentier C. Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma. J Nucl Med. 1996. 37:598–605.
15. Hay ID, Grant CS, van Heerden JA, Goellner JR, Ebersold JR, Bergstralh EJ. Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-year period. Surgery. 1992. 112:1139–1146. discussion 1146-1137.
16. Pellegriti G, Scollo C, Lumera G, Regalbuto C, Vigneri R, Belfiore A. Clinical behavior and outcome of papillary thyroid cancers smaller than 1.5 cm in diameter: study of 299 cases. J Clin Endocrinol Metab. 2004. 89:3713–3720.
17. Sakairi Y, Yasufuku K, Iyoda A, Suzuki M, Nakajima T, Sekine Y, Shibuya K, Takahashi Y, Nakatani Y, Fujisawa T. A solitary metastatic lung tumor from thyroid papillary carcinoma diagnosed by endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA): report of a case. Surg Today. 2008. 38:46–48.